GlassScriptPhysician profile
Donna M Doherty
NPI 1932228954
$2,135.75
in general payments reported to CMS, 2019-2025
21 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $472 · 2022: $659 · 2023: $489 · 2024: $366 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $555.71 | 2021-2024 | Farxiga, Lokelma |
| Novartis Pharmaceuticals Corporation | $523.71 | 2021-2025 | |
| Abbott Laboratories | $209.79 | 2021-2024 | Aveir |
| Novo Nordisk INC | $141.52 | 2022-2024 | Rybelsus, Ozempic |
| Alnylam Pharmaceuticals INC. | $115.26 | 2021-2023 | Amvuttra |
| Kiniksa Pharmaceuticals, LTD. | $83.53 | 2023 | Arcalyst |
| Astellas Pharma US INC | $79.99 | 2021 | |
| Abbvie INC. | $60.88 | 2025 | |
| Amgen INC. | $55.12 | 2022-2023 | Repatha |
| Pfizer INC. | $50.86 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $49.55 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $31.86 | 2024 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $27.82 | 2021 | |
| Cvrx, INC. | $24.72 | 2024 | Barostim Neo System |
| Philips North America LLC | $22.95 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $22.32 | 2024 | Zepbound, Jardiance |
| American Regent | $21.49 | 2022 | |
| Currax Pharmaceuticals LLC | $16.69 | 2021 | |
| Althera Pharmaceuticals LLC | $15.32 | 2021 | |
| Irhythm Technologies, INC. | $14.81 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Doherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.